Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Oncology | Pharmacy | Psychiatry | Reproductive Medicine | Urology | Preventive Medicine | News

Back to Health News

Drug Used to Prevent Prostate Cancer Won’t Lower Quality of Life

Last Updated: September 12, 2012.

 

Proscar is indicated for enlarged prostate; study found it had little long-term detrimental effect

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Proscar is indicated for enlarged prostate; study found it had little long-term detrimental effect.

WEDNESDAY, Sept. 12 (HealthDay News) -- Proscar (finasteride), a drug used to treat an enlarged prostate, does not reduce the quality of life of men who use it for a prolonged period of time, found a new study funded by the U.S. National Cancer Institute.

Published Sept. 12 in the Journal of the National Cancer Institute, the research involved men aged 55 and older enrolled in a seven-year randomized clinical trial looking at the drug's possible use for prostate cancer prevention.

Researchers from the Fred Hutchinson Cancer Research Center in Seattle, led by Carol Moinpour of the public health sciences division, examined three areas of patients' quality of life. Proscar did not significantly affect the men's physical functioning, mental health or vitality, according to a journal news release.

Participants completed questionnaires three months before the study and six months after the study began. They were also surveyed once a year for the next seven years.

Men who smoked or had other health conditions saw more pronounced effects on their quality of life, particularly their physical functioning. The researchers said patients' lifestyles and other health problems should be considered when they are given treatments to prevent disease.

Other factors in the varied group of men made more of a difference than the drug, and "particularly diabetes and current smoking status, had a greater clinically relevant impact on the physical functioning score then did finasteride treatment," the authors wrote.

"Our findings reinforce the need to consider individual differences in age, time on study, smoking status, and [other medical conditions] when evaluating the effect of different preventive interventions on health-related quality of life," they concluded.

More information

The U.S. National Institutes of Health has more about Proscar.

SOURCE: Journal of the National Cancer Institute, news release, Sept. 12, 2012

Copyright © 2012 HealthDay. All rights reserved.


Previous: Family Health Insurance Premiums Jump 4 Percent in 2012 Next: U.S. Expands SIDS Prevention Effort

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.